Key Record Dates
| ClinicalTrials.gov Identifier: | NCT02721732 |
|---|---|
| Brief Title: | Pembrolizumab in Treating Patients With Rare Tumors That Cannot Be Removed by Surgery or Are Metastatic |
| First Submitted : | March 23, 2016 |
| First Submitted that Met QC Criteria : | March 28, 2016 |
| First Posted : | March 29, 2016 (Estimate) |
| Last Update Submitted that Met QC Criteria : | November 30, 2023 |
| Last Update Posted : | December 4, 2023 |